KLK3 and prostate cancer: Up to 35% of patients with localized treatment for prostate cancer (radical prostatectomy or radiation therapy) ultimately present with a biochemical recurrence, which means a prostate specific antigen (PSA) elevation without abnormal conventional imaging studies.